{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:58:23Z","timestamp":1773327503075,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"VA Health Services Research and Developemt","award":["HX001765"],"award-info":[{"award-number":["HX001765"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11606-020-05645-0","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T07:02:50Z","timestamp":1579676570000},"page":"1537-1544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Racial\/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-5028","authenticated-orcid":false,"given":"Utibe R.","family":"Essien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentina E.","family":"Sileanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane M.","family":"Liebschutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn T.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria K.","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Radomski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie R. M.","family":"Hausmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid F.","family":"Gellad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"5645_CR1","unstructured":"Hedegaard H, Warner M, Mini\u00f1o AM. Drug Overdose Deaths in the United States, 1999-2016. 2017. https:\/\/www.cdc.gov\/nchs\/products\/databrieds\/db294.htm. Accessed 2 June 2019."},{"key":"5645_CR2","doi-asserted-by":"publisher","unstructured":"Moyo P, Zhao X, Thorpe CT, et al. Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among Veterans. Res Social Adm Pharm. 2018.\u00a0https:\/\/doi.org\/10.1016\/j.sapharm.2018.10.023","DOI":"10.1016\/j.sapharm.2018.10.023"},{"key":"5645_CR3","doi-asserted-by":"publisher","unstructured":"Wilder CM, Miller SC, Tiffany E, Winhusen T, Winstanley EL, Stein MD. Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. J Addict Dis. 2016. https:\/\/doi.org\/10.1080\/10550887.2016.1107264","DOI":"10.1080\/10550887.2016.1107264"},{"issue":"2","key":"5645_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","volume":"76","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and Treatment of Opioid Misuse and Addiction. JAMA Psychiatry. 2019;76(2):208. doi:https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3126","journal-title":"JAMA Psychiatry."},{"key":"5645_CR5","doi-asserted-by":"publisher","unstructured":"Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose: A cohort study. Ann Intern Med. 2016. https:\/\/doi.org\/10.7326\/M15-0038","DOI":"10.7326\/M15-0038"},{"key":"5645_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1001\/jamapediatrics.2018.2143","volume":"02118","author":"SE Hadland","year":"2018","unstructured":"Hadland SE, Bagley SM, Rodean J, et al. Receipt of Timely Addiction Treatment and Association of Early Medication Treatment with Retention in Care among Youths with Opioid Use Disorder. JAMA Pediatr. 2018;02118:E1-E9. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.2143","journal-title":"JAMA Pediatr."},{"key":"5645_CR7","doi-asserted-by":"publisher","unstructured":"Valenstein-Mah H, Hagedorn H, Kay CL, Christopher ML, Gordon AJ. Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration. Subst Abus. 2018. https:\/\/doi.org\/10.1080\/08897077.2018.1509251","DOI":"10.1080\/08897077.2018.1509251"},{"key":"5645_CR8","doi-asserted-by":"publisher","unstructured":"Wyse JJ, Gordon AJ, Dobscha SK, et al. Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Subst Abus. 2018. https:\/\/doi.org\/10.1080\/08897077.2018.1452327","DOI":"10.1080\/08897077.2018.1452327"},{"key":"5645_CR9","doi-asserted-by":"publisher","unstructured":"Frazier W, Cochran G, Lo-Ciganic WH, et al. Medication-assisted treatment and opioid use before and after overdose in Pennsylvania Medicaid. J Am Med Assoc. 2017. https:\/\/doi.org\/10.1001\/jama.2017.7818","DOI":"10.1001\/jama.2017.7818"},{"issue":"3","key":"5645_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Ann Intern Med. 2018;169(3):137\u2013145. https:\/\/doi.org\/10.7326\/M17-3107","journal-title":"Ann Intern Med."},{"key":"5645_CR11","doi-asserted-by":"publisher","unstructured":"Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine Treatment Divide by Race\/Ethnicity and Payment. JAMA Psychiatry. 2019. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0876","DOI":"10.1001\/jamapsychiatry.2019.0876"},{"key":"5645_CR12","doi-asserted-by":"publisher","unstructured":"Alexander MJ, Kiang MV, Barbieri M. Trends in Black and White Opioid Mortality in the United States, 1979-2015. Epidemiology. 2018. https:\/\/doi.org\/10.1097\/EDE.0000000000000858","DOI":"10.1097\/EDE.0000000000000858"},{"issue":"7","key":"5645_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","volume":"12","author":"DC Cowper","year":"2002","unstructured":"Cowper DC, Kubal JD, Maynard C, Hynes DM. A Primer and Comparative Review of Major U.S. Mortality Databases. Ann Epidemiol. 2002;12(7):462\u2013468. https:\/\/doi.org\/10.1016\/S1047-2797(01)00285-X","journal-title":"Ann Epidemiol."},{"key":"5645_CR14","doi-asserted-by":"publisher","unstructured":"Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf. 2017. https:\/\/doi.org\/10.1002\/pds.4157","DOI":"10.1002\/pds.4157"},{"key":"5645_CR15","doi-asserted-by":"publisher","unstructured":"Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.10.004","DOI":"10.1016\/j.jclinepi.2010.10.004"},{"key":"5645_CR16","doi-asserted-by":"publisher","unstructured":"Thorpe CT, Gellad WF, Mor MK, et al. Effect of Dual Use of Veterans Affairs and Medicare Part D Drug Benefits on Antihypertensive Medication Supply in a National Cohort of Veterans with Dementia. Health Serv Res. 2018. https:\/\/doi.org\/10.1111\/1475-6773.13055","DOI":"10.1111\/1475-6773.13055"},{"key":"5645_CR17","unstructured":"Massachusetts Department of Public Health. MA Opioid-Related EMS Incidents 2013-September 2018. 2019. https:\/\/www.mass.gov\/files\/documents\/2019\/02\/12\/Emergency-Medical-Services-Data-February-2019.pdf. Accessed April 17, 2019."},{"key":"5645_CR18","doi-asserted-by":"publisher","unstructured":"Nahin RL. Severe Pain in Veterans: The Effect of Age and Sex, and Comparisons With the General Population. J Pain. 2017. https:\/\/doi.org\/10.1016\/j.jpain.2016.10.021","DOI":"10.1016\/j.jpain.2016.10.021"},{"key":"5645_CR19","doi-asserted-by":"publisher","unstructured":"Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States: Lessons from the department of veterans affairs. JAMA Intern Med. 2017. https:\/\/doi.org\/10.1001\/jamainternmed.2017.0147","DOI":"10.1001\/jamainternmed.2017.0147"},{"issue":"31","key":"5645_CR20","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1200\/JCO.2009.22.9773","volume":"27","author":"NA Bickell","year":"2009","unstructured":"Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H. Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol. 2009;27(31):5160\u20135167. https:\/\/doi.org\/10.1200\/JCO.2009.22.9773","journal-title":"J Clin Oncol."},{"key":"5645_CR21","doi-asserted-by":"publisher","unstructured":"Chinman M, Gellad WF, McCarthy S, et al. Protocol for evaluating the nationwide implementation of the VA Stratification Tool for Opioid Risk Management (STORM). Implement Sci. 2019. https:\/\/doi.org\/10.1186\/s13012-019-0852-z","DOI":"10.1186\/s13012-019-0852-z"},{"key":"5645_CR22","unstructured":"The Management of Substance Use DIsorders. VA \/ DoD Clinical Practice Guideline for the Management of Substance Use Disorders. Assessment. 2015."},{"key":"5645_CR23","doi-asserted-by":"publisher","unstructured":"Wen H, Hockenberry JM, Jeng PJ, Bao Y. Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use. Health Aff. 2019. https:\/\/doi.org\/10.1377\/hlthaff.2019.00103","DOI":"10.1377\/hlthaff.2019.00103"},{"issue":"3","key":"5645_CR24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","volume":"40","author":"HB Hansen","year":"2013","unstructured":"Hansen HB, Siegel CE, Case BG, Bertollo DN, DiRocco D, Galanter M. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Serv Res. 2013;40(3):367\u2013377. https:\/\/doi.org\/10.1007\/s11414-013-9341-3","journal-title":"J Behav Health Serv Res."},{"key":"5645_CR25","doi-asserted-by":"publisher","unstructured":"Wyse JJ, Robbins JL, McGinnis KA, et al. Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug Alcohol Depend. 2019. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.038","DOI":"10.1016\/j.drugalcdep.2019.01.038"},{"key":"5645_CR26","doi-asserted-by":"publisher","unstructured":"Hausmann LRM, Gao S, Lee ES, Kwoh CK. Racial disparities in the monitoring of patients on chronic opioid therapy. Pain. 2013. https:\/\/doi.org\/10.1016\/j.pain.2012.07.034","DOI":"10.1016\/j.pain.2012.07.034"},{"key":"5645_CR27","doi-asserted-by":"publisher","unstructured":"Manhapra A, Quinones L, Rosenheck R. Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration. Drug Alcohol Depend. 2016. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.035","DOI":"10.1016\/j.drugalcdep.2015.12.035"},{"issue":"13","key":"5645_CR28","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jama.2019.12562","volume":"322","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey PJ, Edelman EJ, Wang EA. Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States. JAMA. 2019;322(13):1310. https:\/\/doi.org\/10.1001\/jama.2019.12562","journal-title":"JAMA."},{"key":"5645_CR29","doi-asserted-by":"publisher","unstructured":"Dick A, Pacula R, Gordon AJ, et al. Increasing access to opioid agonist treatment in U.S. treatment shortage areas. Drug Alcohol Depend. 2015. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.09.189","DOI":"10.1016\/j.drugalcdep.2014.09.189"},{"key":"5645_CR30","doi-asserted-by":"publisher","unstructured":"Oliva EM, Trafton JA, Harris AHS, Gordon AJ. Trends in opioid agonist therapy in the veterans health administration: Is supply keeping up with demand? Am J Drug Alcohol Abuse. 2013. https:\/\/doi.org\/10.3109\/00952990.2012.741167","DOI":"10.3109\/00952990.2012.741167"},{"key":"5645_CR31","doi-asserted-by":"publisher","unstructured":"Meints SM, Cortes A, Morais CA, Edwards RR. Racial and ethnic differences in the experience and treatment of noncancer pain. Pain Manag. 2019. https:\/\/doi.org\/10.2217\/pmt-2018-0030","DOI":"10.2217\/pmt-2018-0030"},{"issue":"6","key":"5645_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s11606-008-0561-9","volume":"23","author":"K Armstrong","year":"2008","unstructured":"Armstrong K, McMurphy S, Dean LT, et al. Differences in the patterns of health care system distrust between blacks and whites. J Gen Intern Med. 2008;23(6):827\u2013833. https:\/\/doi.org\/10.1007\/s11606-008-0561-9","journal-title":"J Gen Intern Med."},{"key":"5645_CR33","doi-asserted-by":"publisher","unstructured":"Whetten K, Leserman J, Whetten R, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health. 2006. doi:https:\/\/doi.org\/10.2105\/AJPH.2005.063255","DOI":"10.2105\/AJPH.2005.063255"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-020-05645-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T01:07:26Z","timestamp":1611191246000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-020-05645-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5645"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-05645-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"23 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Gellad, Dr. Hausmann, and Dr. Thorpe report received grants from the Department of Veterans Affairs during the conduct of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}